Harnessing RWE to Drive Diversity, Equity, & Inclusion in Clinical Trials to Meet Regulatory Guidance
Time: 2:00 pm
day: Conference Day Two
Details:
• Using RWD to understand your patient population and their geographies to demonstrate the reality
• Informing clinical trial exclusion and inclusion criteria to ensure representation of the patient population and prevent mismatch to disease population
• Applying these insights to meet the FDA’ diversity action plans
